comparemela.com

Latest Breaking News On - Investor relations for citius pharmaceuticals - Page 4 : comparemela.com

Citius Pharmaceuticals, Inc Holds Pre-BLA Meeting with the FDA for I/ONTAK (denileukin diftitox) for the Treatment of Cutaneous T-Cell Lymphoma

/PRNewswire/ Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing.

United statesIlanit allenLeonard mazurCompany nasdaqDrug administrationExchange commissionPrnewswire citius pharmaceuticals incCorporate communicationsSecurities exchangeInvestor relations for citius pharmaceuticalsCitius pharmaceuticals incBiologics license applicationDrug evaluationCitius pharmaceuticalsFast trackSecurities act

Citius Pharmaceuticals, Inc Announces Intention to Spinoff Late-Stage Oncology Asset, I/ONTAK, into a New Standalone Publicly Traded Company

/PRNewswire/ Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing.

Ilanit allenLeonard mazurNovecite incCompany nasdaqDrug administrationExchange commissionPrnewswire citius pharmaceuticals incCorporate communicationsSecurities exchangeInvestor relations for citius pharmaceuticalsCitius pharmaceuticals incCitius boardCitius pharmaceuticalsPivotal phaseFast trackSecurities act

Citius Pharmaceuticals to Present at the H C Wainwright Global Investment Conference on May 24, 2022

/PRNewswire/ Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing.

United statesMiami beachIlanit allenLeonard mazurNovecite incCompany nasdaqDrug administrationFontainebleau miami beach hotelCorporate communicationsPrnewswire citius pharmaceuticals incInvestor relations for citius pharmaceuticalsCitius pharmaceuticals incInvestment conferenceInvestor conferenceCitius pharmaceuticalsPivotal phase

Citius Pharmaceuticals to Present at the H C Wainwright Global Investment Conference on May 24, 2022

CRANFORD, N.J., May 18, 2022 /PRNewswire/ Citius Pharmaceuticals, Inc. ( Citius or the Company ) (Nasdaq: CTXR), a late-stage biopharmaceutic.

United statesMiami beachIlanit allenLeonard mazurNovecite incCompany nasdaqDrug administrationFontainebleau miami beach hotelCorporate communicationsPrnewswire citius pharmaceuticals incInvestor relations for citius pharmaceuticalsCitius pharmaceuticals incInvestment conferenceInvestor conferenceCitius pharmaceuticalsPivotal phase

Citius Pharmaceuticals, Inc Reports Fiscal Second Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing.

Ilanit allenLeonard mazurNovecite incCompany nasdaqDrug administrationExchange commissionDevelopment rd expensesPrnewswire citius pharmaceuticals incCorporate communicationsSecurities exchangeCitius pharmaceuticals incInvestor relations for citius pharmaceuticalsHalo lido phaseCitius pharmaceuticalsPivotal phaseFast track

vimarsana © 2020. All Rights Reserved.